| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52a65b677bbedbe7bf090dd556a7cc43 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2001-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b65c5827a0e6469bef6c6900537c901 |
| publicationDate |
2003-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2003128589-A |
| titleOfInvention |
Immunostimulants |
| abstract |
PROBLEM TO BE SOLVED: To provide an adjuvant for vaccine which is excellent in sustained-release property and immunostimulatory property of an antigen and has high safety. SOLUTION: An adjuvant for vaccine contains ε-polylysine as an immunostimulant. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9127322-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2332969-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2194063-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8796027-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006304644-A |
| priorityDate |
2001-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |